Signifor is an orphan drug approved in the United States and Europe for the treatment of Cushing’s disease in patients who fail or are ineligible for surgical therapy. The global market for Signifor Drugs was estimated to…
Author: QYResearch
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 6 countries (include United States, Germany, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Pegvisomant Drugs Market Growth 2024-2030: Targeting Key Segments and Strategies for Expansion
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global market for Pegvisomant Drugs was estimated to be worth US$ 268 million in 2023 and is forecast to a readjusted…
Somavert Drugs Market Opportunity Analysis Report 2024: Regional Markets and Segments
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global market for Somavert Drugs was estimated to be worth US$ 268 million in 2023 and is forecast to a readjusted…
Lanreotide Drugs Market Growth in 2024-2030: Dynamics, Opportunities, and Strategies
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The global market for Lanreotide Drugs was estimated to be worth US$ 1401 million in 2023…
Somavert Global Market in 2024: A Comprehensive Analysis of Opportunities and Threats
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global market for Somavert was estimated to be worth US$ 268 million in 2023 and is forecast to a readjusted size…
Somatuline Drugs Global Market Report 2024: Pricing, Distribution, and Promotion – Strategies for Success
Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The global market for Somatuline Drugs was estimated to be worth US$ 1401 million in 2023…
Pegvisomant Global Market Report 2024: Pricing, Distribution, and Promotion – Strategies for Success
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global market for Pegvisomant was estimated to be worth US$ 268 million in 2023 and is forecast to a readjusted size…
Sandostatin LAR Drugs Global Market Research 2024: Industry Trends, Share, Market Size, and Outlook
Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. The global market for Sandostatin LAR Drugs was estimated to be…
Soliris Drug Market Report 2024: Data-Driven Insights on Trends and Opportunities
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The global market for Soliris Drug was estimated to be worth US$ 3762 million…
Orthopedic Hyaluronic Acid Viscosupplementation Global and Regional Perspectives on Market Size, Share, and Analysis 2024-2030
Viscosupplementation is a medical treatment for knee osteoarthritis during which lubricating fluid is injected into the knee joint to reduce pain symptoms. The global market for Orthopedic Hyaluronic Acid Viscosupplementation was estimated to…